BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7902734)

  • 1. An HTLV-I carrier who developed CD4+ T-CLL expressed the IL-2 receptor beta chain alone without expressing the alpha chain.
    Mori N; Murakami S; Oda S; Eto S
    Br J Haematol; 1993 Sep; 85(1):185-7. PubMed ID: 7902734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemic cells from a chronic T-lymphocytic leukemia patient proliferated in response to both interleukin-2 and interleukin-4 without prior stimulation and produced interleukin-2 mRNA with stimulation.
    Umadome H; Uchiyama T; Onishi R; Hori T; Uchino H; Nesumi N
    Blood; 1988 Oct; 72(4):1177-81. PubMed ID: 3262382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism.
    Horiuchi S; Koyanagi Y; Tanaka Y; Waki M; Matsumoto A; Zhou YW; Yamamoto M; Yamamoto N
    Immunology; 1997 May; 91(1):28-34. PubMed ID: 9203962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 receptor beta-chain (p70-75) expressed on leukemic cells from adult T cell leukemia patients.
    Kodaka T; Uchiyama T; Ishikawa T; Kamio M; Onishi R; Itoh K; Hori T; Uchino H; Tsudo M; Araki K
    Jpn J Cancer Res; 1990 Sep; 81(9):902-8. PubMed ID: 2121691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals.
    Rebollo A; Silva A
    Immunology; 1993 Oct; 80(2):229-35. PubMed ID: 8262551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
    Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
    Leukemia; 1994 Sep; 8(9):1571-8. PubMed ID: 8090033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory mechanisms for the expression of a functional beta chain of interleukin 2 receptor on T4 chronic lymphocytic leukemia cells.
    Maeda Y; Hattori T; Sakai K; Yamamura Y; Murakami T; Asou N; Tsudo M; Takatsuki K
    Growth Factors; 1991; 4(4):289-95. PubMed ID: 1764265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of murine IL-2 receptor beta-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor alpha-chain transgenic mice.
    Hattori M; Okazaki H; Ishida Y; Onuma M; Kano S; Honjo T; Minato N
    J Immunol; 1990 May; 144(10):3809-15. PubMed ID: 2332632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.
    Tendler CL; Greenberg SJ; Blattner WA; Manns A; Murphy E; Fleisher T; Hanchard B; Morgan O; Burton JD; Nelson DL
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5218-22. PubMed ID: 2367534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells.
    Nakase K; Kita K; Otsuji A; Anazawa H; Hoshino K; Sekine T; Shirakawa S; Tanaka I; Nasu K; Tsutani H
    Br J Haematol; 1992 Mar; 80(3):317-26. PubMed ID: 1581211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth.
    Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J
    Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
    Bamford RN; Grant AJ; Burton JD; Peters C; Kurys G; Goldman CK; Brennan J; Roessler E; Waldmann TA
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4940-4. PubMed ID: 8197161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies to the rabbit interleukin-2 receptor alpha chain (CD25) and its distribution in HTLV-1-transformed rabbit T cells.
    Kotani M; Yamamura Y; Tsudo M; Tamatani T; Kitamura F; Miyasaka M
    Jpn J Cancer Res; 1993 Jul; 84(7):770-5. PubMed ID: 8370651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
    Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
    Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor ligation induces interleukin (IL) 2R beta chain expression in rat CD4,8 double positive thymocytes, initiating an IL-2-dependent differentiation pathway of CD8 alpha+/beta- T cells.
    Park JH; Mitnacht R; Torres-Nagel N; Hünig T
    J Exp Med; 1993 Feb; 177(2):541-6. PubMed ID: 8426123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
    Park JH; Hanke T; Hünig T
    Eur J Immunol; 1996 Oct; 26(10):2371-5. PubMed ID: 8898947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30-positive lymphoma in human T-cell leukaemia virus type 1 carrier without monoclonal integration of HTLV-1.
    Hori M; Mitsuhashi S; Kobayashi T; Nagasawa T; Mori N; Miwa M; Abe T
    Br J Haematol; 1994 Oct; 88(2):419-20. PubMed ID: 7803296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes.
    Zambello R; Pizzolo G; Trentin L; Agostini C; Chisesi T; Vinante F; Scarselli E; Zanotti R; Vespignani M; De Rossi G
    Cancer; 1989 Nov; 64(10):2019-23. PubMed ID: 2804889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
    Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).
    Shindo T; Sugie K; Nakamura K; Tagaya Y; Maeda M; Uchiyama T; Sagawa K; Yokoyama M; Wada H; Hitomi S
    Immunology; 1990 Sep; 71(1):63-9. PubMed ID: 2170270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.